Wiki-Pi

Search Results for: Diabetes

3097 interactions found:

Sort by: Relevance Number of Pathways Number of Drugs Number of Diseases
Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ZAP70 and SH2B3 zeta-chain (TCR) associated protein kinase 70kDa SH2B adaptor protein 3
  • TCR signaling
  • Generation of second messenger molecules
  • Translocation of ZAP-70 to Immunological synapse
  • Adaptive Immune System
  • Signaling by SCF-KIT
  • Regulation of KIT signaling
  • Factors involved in megakaryocyte development and platelet production
  • Staurosporine
ZAP70 and PTPN22 zeta-chain (TCR) associated protein kinase 70kDa protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
  • TCR signaling
  • Generation of second messenger molecules
  • Translocation of ZAP-70 to Immunological synapse
  • Adaptive Immune System
  • Staurosporine
MAFK and BACH2 v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K BTB and CNC homology 1, basic leucine zipper transcription factor 2
  • Factors involved in megakaryocyte development and platelet production
CREB5 and SPRY2 cAMP responsive element binding protein 5 sprouty homolog 2 (Drosophila)
  • Signaling by EGFR
  • EGFR downregulation
  • Signaling by FGFR in disease
  • Signaling by EGFR in Cancer
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by EGFRvIII in Cancer
  • Spry regulation of FGF signaling
  • Signaling by FGFR
  • Negative regulation of FGFR signaling
NFE2L3 and BACH2 nuclear factor, erythroid 2-like 3 BTB and CNC homology 1, basic leucine zipper transcription factor 2
USP3 and IFIH1 ubiquitin specific peptidase 3 interferon induced with helicase C domain 1
  • TRAF3-dependent IRF activation pathway
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Negative regulators of RIG-I/MDA5 signaling
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • Innate Immune System
SPRY2 and UBASH3A sprouty homolog 2 (Drosophila) ubiquitin associated and SH3 domain containing A
  • Signaling by EGFR
  • EGFR downregulation
  • Signaling by FGFR in disease
  • Signaling by EGFR in Cancer
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by EGFRvIII in Cancer
  • Spry regulation of FGF signaling
  • Signaling by FGFR
  • Negative regulation of FGFR signaling
FOXP3 and IKZF4 forkhead box P3 IKAROS family zinc finger 4 (Eos)
SUFU and GLIS3 suppressor of fused homolog (Drosophila) GLIS family zinc finger 3
  • Hedgehog 'off' state
  • Hedgehog 'on' state
  • Signaling by Hedgehog
  • Degradation of GLI1 by the proteasome
  • GLI3 is processed to GLI3R by the proteasome
  • Degradation of GLI2 by the proteasome
BATF3 and BACH2 basic leucine zipper transcription factor, ATF-like 3 BTB and CNC homology 1, basic leucine zipper transcription factor 2
PATZ1 and BACH2 POZ (BTB) and AT hook containing zinc finger 1 BTB and CNC homology 1, basic leucine zipper transcription factor 2
MAFF and BACH2 v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F BTB and CNC homology 1, basic leucine zipper transcription factor 2
  • Factors involved in megakaryocyte development and platelet production
CREB3L1 and SLC30A8 cAMP responsive element binding protein 3-like 1 solute carrier family 30 (zinc transporter), member 8
  • Metal ion SLC transporters
  • Peptide hormone metabolism
  • Zinc efflux and compartmentalization by the SLC30 family
  • Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
  • Insulin processing
  • Zinc transporters
  • SLC-mediated transmembrane transport
A2M and IL10 alpha-2-macroglobulin interleukin 10
  • Lipoprotein metabolism
  • Metabolism of lipids and lipoproteins
  • Platelet degranulation
  • Lipid digestion, mobilization, and transport
  • Degradation of the extracellular matrix
  • Formation of Fibrin Clot (Clotting Cascade)
  • Rho GTPase cycle
  • Intrinsic Pathway
  • HDL-mediated lipid transport
  • Response to elevated platelet cytosolic Ca2+
  • Signaling by Rho GTPases
  • Platelet activation, signaling and aggregation
  • Becaplermin
  • Bacitracin
  • Ocriplasmin
AAMP and PTF1A angio-associated, migratory cell protein pancreas specific transcription factor, 1a
  • Regulation of beta-cell development
  • Regulation of gene expression in early pancreatic precursor cells
ABCA1 and LMO7 ATP-binding cassette, sub-family A (ABC1), member 1 LIM domain 7
  • Lipoprotein metabolism
  • PPARA activates gene expression
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • HDL-mediated lipid transport
  • Metabolism of lipids and lipoproteins
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Lipid digestion, mobilization, and transport
  • Adenosine triphosphate
  • Glyburide
  • Probucol
ABL1 and ERBB4 ABL proto-oncogene 1, non-receptor tyrosine kinase erb-b2 receptor tyrosine kinase 4
  • Role of Abl in Robo-Slit signaling
  • CDO in myogenesis
  • Axon guidance
  • Myogenesis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Signaling by Robo receptor
  • Regulation of actin dynamics for phagocytic cup formation
  • Innate Immune System
  • Adenosine triphosphate
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • MYRISTIC ACID
  • 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
ABL1 and SRC ABL proto-oncogene 1, non-receptor tyrosine kinase SRC proto-oncogene, non-receptor tyrosine kinase
  • Role of Abl in Robo-Slit signaling
  • CDO in myogenesis
  • Axon guidance
  • Myogenesis
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Signaling by Robo receptor
  • Regulation of actin dynamics for phagocytic cup formation
  • Innate Immune System
  • Signaling by ERBB2
  • Adenosine triphosphate
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • MYRISTIC ACID
  • 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
  • Dasatinib
  • RU84687
  • RU79256
  • N6-Benzyl Adenosine-5\'-Diphosphate
  • RU85493
  • RU78262
  • Phosphonotyrosine
  • Malonic acid
  • RU83876
  • RU90395
  • RU79072
  • RU78783
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • PASBN
  • RU82129
  • PAS219
  • DPI59
  • RU82197
  • Phenylphosphate
  • RU78300
  • RU79073
  • RU82209
  • ISO24
  • RU85053
  • RU78299
  • Oxalic Acid
  • RU78191
  • Citric Acid
  • RU81843
  • 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
  • Purvalanol A
  • Bosutinib
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
  • 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
  • N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
  • (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
  • Ponatinib
ABL2 and ERBB4 ABL proto-oncogene 2, non-receptor tyrosine kinase erb-b2 receptor tyrosine kinase 4
  • Role of Abl in Robo-Slit signaling
  • Axon guidance
  • Signaling by Robo receptor
  • Adenosine triphosphate
  • Dasatinib
  • 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
ABO and GRAMD3 ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) GRAM domain containing 3
  • Uridine-Diphosphate-N-Acetylgalactosamine
  • Uridine-5\'-Diphosphate
  • Uridine Diphosphate Galactose
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • H TYPE II TRISACCHARIDE
  • H TYPE I TRISACCHARIDE
  • GALACTOSE GREASE
  • BETA-METHYLLACTOSIDE
  • octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside
  • 4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
  • 4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
  • octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside

Page 32 out of 155 pages